RiSKWa - Joint project COVIDready: Decentralised SARS-CoV-2 monitoring in wastewater: Development of a validated analysis method for wastewater technology laboratories at sewage treatment plants, Sub… | Pandemic PACT Tracker

Key facts

Disease
COVID-19
Start & end year
2021
2023
Known Financial Commitments (USD)
$440,876.29
Funder
Bundesministerium für Bildung und Forschung [German Federal Ministry of Education and Research] (BMBF)
Principal Investigator
N/A
Research Location
Germany
Lead Research Institution
Johann Wolfgang Goethe-Universität Frankfurt am Main
Research Priority Alignment
N/A

Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Diagnostics
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable

Abstract

Publicationslinked via Europe PMC

Last Updated:41 minutes ago

View all publications at Europe PMC

Molecular Analyses of Clinical Isolates and Recombinant SARS-CoV-2 Carrying B.1 and B.1.617.2 Spike Mutations Suggest a Potential Role of Non-Spike Mutations in Infection Kinetics.

Reply to Fabbris et al. A Viable Alternative. Comment on "Kohmer et al. Self-Collected Samples to Detect SARS-CoV-2: Direct Comparison of Saliva, Tongue Swab, Nasal Swab, Chewed Cotton Pads and Gargle Lavage. J. Clin. Med. 2021, 10, 5751".

Antibody-Mediated Neutralization of Authentic SARS-CoV-2 B.1.617 Variants Harboring L452R and T478K/E484Q.

Limited Neutralization of Authentic Severe Acute Respiratory Syndrome Coronavirus 2 Variants Carrying E484K In Vitro.